Rasagiline (Azilai) medication time recommendations and daily medication guidance

Rasagiline (Rasagiline) is a selective monoamine oxidase B (MAO-B) inhibitor. It is mainly used for the early treatment of Parkinson's disease or in combination with levodopa for patients with advanced disease to improve motor symptoms and delay "on-off" fluctuations. Reasonable medication time and daily medication guidance are crucial to the efficacy and side effects management.

It is generally recommended to take rasagiline orally once a day at a fixed time, usually in the morning. Taking medicine in the morning can be coordinated with your daily routine to avoid adverse reactions to the central nervous system such as insomnia or dreaminess at night. The drug can be taken on an empty stomach or with food, but the taking time should be kept as consistent as possible every day to maintain stable blood concentration and ensure sustained efficacy.

In daily medication, patients should be careful to avoid combined use with irreversible non-selective MAO inhibitors (such as phenelzine antidepressants) to prevent severe hypertensive crisis. In addition, some foods containing high tyrosine or other monoamine components (such as a large amount of cheese, cured meats) usually will not cause severe reactions at selective doses of MAO-B, but patients still need to maintain a balanced diet under the guidance of a doctor to avoid extreme situations.

At the same time, patients should pay attention to monitoring changes in blood pressure, heart rate and self-motor symptoms while using rasagiline, especially when combined with levodopa treatment. If dizziness, hypotension, insomnia or excessive exercise occur, you should communicate with your doctor promptly to evaluate whether to adjust the dose or medication time. Adhering to fixed medication schedules, avoiding dangerous drug combinations, and regular monitoring can maximize the efficacy of rasagiline while reducing the risk of adverse reactions.

Reference link:https://www.drugs.com